Home > Focus Areas > Sleep Disorder Connect > Post
  • Saved
Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) - PubMed

Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/37099213/

This is a summary of the original article 'Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)'. Individuals with insomnia are best positioned to assess the impact of insomnia on their quality of life. Patient reported outcomes (PROs) are self-reported healt ...

Abstract: This is a summary of the original article ‘Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)’. Individuals with insomnia are best positioned to assess the impact of insomnia on their quality of life. Patient reported outcomes (PROs) are self-reported health measures created to allow people to record their experience of their disease. Chronic insomnia has a major impact on daytime functioning for patients, and on their quality of life. This summary of research provides an overview of a previously published article detailing the development and evaluation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ), as a tool to allow people with insomnia to report their experience of the impact on their daytime functioning.

  • 3yr
    Key Points
    • Source: Advances in Therapy
    • Conclusions: “This summary of research provides an overview of a previously published article detailing the development and evaluation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ), as a tool to allow people with insomnia to report their experience of the impact on their daytime functioning.”
    • IDSIQ is the first patient-reported outcome (PRO) tool developed and validated per FDA guidelines and used to assess daytime sleepiness in patients with insomnia. Symptoms of daytime sleepiness include fatigue, sleepiness, mood disturbance/irritability, reduced energy, and issues with attention/memory.
    • Authors of the study reviewed several extant questionnaires for daytime function, and they all had limitations. The Daytime Insomnia Symptom Scale (DISS) came closest to representing the feelings and experiences of patients with chronic insomnia.
    • The IDSIQ is a 14-item questionnaire that is easy to complete by the patient and can be used in trials of insomnia therapies and observational studies examining changes in daytime functioning. Lower scores represent improvements in daytime functioning.